Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates 2018-02-14 21:30
China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial Results 2018-02-14 21:00
China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial Results 2018-02-14 21:00
MyGenomeBox Wins 2018 BIG Innovation Award 2018-02-13 22:00
Cedrus Investments' Chairman Mr. Rani Jarkas is Invited to Speak at the Hong Kong Biotech Invest and Partnering 2018 2018-02-13 16:00
Ping An Technology Applies AI to Healthcare, Delivering Solutions that Benefit the General Public 2018-02-13 15:15
Ondine Biomedical Inc. Announces the Appointment of Joseph Sowell, III to Board of Directors 2018-02-13 07:52
Saama Technologies Earns Frost & Sullivan's Recognition as a Technology Leader, with its Real-World Evidence IT Solutions 2018-02-12 21:00
JHL Biotech's Final Trading Day on Taipei Exchange 2018-02-12 08:00
Ondine Biomedical, Inc. Announces the Appointment of Vicente Fox, Former President of Mexico (2000 - 2006) to Board of Directors 2018-02-09 10:42
WuXi Biologics Congratulates Tychan for Dosing First Patient of a Zika Antibody after Record 9 Months of Development 2018-02-09 09:04
DT MedTech Announces Successful Implantations of the New Hintermann Series H2™ Total Ankle Replacement Prosthesis 2018-02-08 07:35
Sinovac Provides Update on Going Private Transaction 2018-02-07 21:50
Sinovac Holds 2017 Annual General Meeting of Shareholders 2018-02-07 21:48
China Cord Blood Corporation to Change Corporate Name to "Global Cord Blood Corporation" 2018-02-07 20:00
Golden Meditech Announces FDA Registration of GMP Manufacturing Facility by its Associate, Cellenkos, Inc. 2018-02-07 17:31
WuXi AppTec Launches Advanced Library Compound Initiative on LabNetwork.com 2018-02-06 21:00
Frost & Sullivan Publishes Update Coverage Report on DNA Biomedical Solutions Ltd.: Entera's unsuccessful NASDAQ IPO is not expected to have a significant impact on its clinical plans; Price target affected by a change in the exchange rate. 2018-02-06 18:07
Tessa Therapeutics Announces Opening of Recruitment Sites Across the United States for its Phase III Nasopharyngeal Cancer Immunotherapy Trial 2018-02-06 07:00
JHL Biotech's Application to Voluntarily Terminate Trading of Shares Approved by Taipei Exchange 2018-02-05 08:53
1 335 336 337 338 339 440